Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Vol. 47/No. RR-5.

Keywords

Medicine, Human immunodeficiency virus (HIV), Disease, Viral load, Immunology

References

No references recorded for this paper.

Cited by

• Assay of Plasma Samples Representing Different HIV-1 Genetic Subtypes: An Evaluation of New Versions of the Amplicor HIV-1 Monitor AssayMartine Delefosse — 1999
• Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance StudyKenichi Kurata — 1999
• Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task ForceChatarrería Córdoba — 2005
• Use of antiretroviral HIV post-exposure prophylaxis in sexually abused children and adolescents treated in an inner-city pediatric emergency department.康充 米, 賀一郎 笹 — 2006
• Use of predictive markers of HIV disease progression in vaccine trials.T. Kushima — 2009
• Cost-Effectiveness of Counseling and Testing to Prevent Sexual Transmission of HIV in the United StatesPaul G. Farnham, Steven D. Pinkerton, David R. Holtgräve — 2002
• Special considerations regarding antiretroviral therapy and infection prophylaxis in the HIV-infected individual with cancer.Joseph A. Sparano, Gary Kalkut — 2001
• Epidemiology of HIV-associated malignancies.Luigino Dal Maso, Diego Serraino, Silvia Franceschi — 2001
• The History and Practice of College HealthH. Spencer Turner, Janet Hurley — 2015
• Strategies for second-line antiretroviral therapy in adults with HIV infection.Ann C. Collier, Margot A. Schwartz — 1999
• Antiretroviral Therapy: When to StartChristopher J. Sellers, David A. Wohl — 2014
• First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better.Josep M. Llibre — 2009
• A National Study of the Relationship of Care Site HIV Specialization to Early Adoption of Highly Active Antiretroviral TherapyIra B. Wilson, Bruce E. Landon, Lin Ding — 2005
• Safe and effective use of combination antiretroviral treatment.Robert Colebunders, Nathan Clumeck, Éric Florence — 1999
• HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996.J Anderson, James W. Carey, Samuel Taveras — 2000
• The Maternal and Child Health Sites' Practices Regarding HIV Education, Counseling, and Testing of Women of Reproductive Age in Chicago: Barriers to Universal ImplementationAfsaneh Rahimian, Mary Driscoll, Dean C. Taylor — 1998
• The Influence of Donor and Reservoir Additives on Caco-2 Permeability and Secretory Transport of HIV Protease Inhibitors and Other Lipophilic CompoundsBruce J. Aungst, Nhung H. A. Nguyen, James P. Bulgarelli — 2000
• Identifying structural barriers to antiretroviral therapy adherenceJacomina Hendrina Vermeulen — 2011
• Future implications: compliance and failure with antiretroviral treatment.Atul Patel, Patel Kk — 2006
• Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens.Frederick S. Nolte — 1998

Related papers

• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.Frank J. Palella, Kathleen M. Delaney, Anne C. Moorman — 1998
• Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.Charles C. J. Carpenter, Margaret A. Fischl, Scott M. Hammer — 1998
• Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionJohn W. Mellors, Alvaro Munoz, Janis V. Giorgi — 1997
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.K. G. Castro, Jill Ward, Laurence Slutsker — 1993
• A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.Scott M. Hammer, Kathleen Squires, Michael D. Hughes — 1997
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaJohn W. Mellors, Charles R. Rinaldo, Phalguni Gupta — 1996
• Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.William A. O’Brien, Pamela Hartigan, David E. Martin — 1996
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000A. Fauci, J. Bartlett, E. Goosby — 1998
• Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.Roy M. Gulick, John W. Mellors, Diane V. Havlir — 1997
• Surveillance for waterborne-disease outbreaks--United States, 1995-1996.Aurora B. Lê, Michelle S. Bens, G F Craun — 1998